Previous close | 9.25 |
Open | 9.60 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 35.00 |
Expiry date | 2024-06-21 |
Day's range | 9.25 - 9.60 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ’s expansion in the cardiovascular space with the $13.1 billion acquisition of heart device firm Shockwave Medical Inc (NASDAQ: SWAV). First Quarter Highlights For the period ended in March, the healthcare company posted a revenue
Pfizer (PFE) closed the most recent trading day at $25.91, moving +0.19% from the previous trading session.
In this article, we will take a detailed look at the 10 Micro-Cap Healthcare Stocks Insiders Are Buying. For a quick overview of such stocks, read our article 5 Micro-Cap Healthcare Stocks Insiders Are Buying. Investors have always been interested in the connection between insider buying and stock returns. Over the past several years there’s been a huge influx […]